Capvaxive

Capvaxive is a vaccine designed to protect against pneumococcal infections. It contains pneumococcal polysaccharides conjugated to CRM197, offering targeted immunity. Learn more about this vaccine's uses and benefits.

Capvaxive is primarily used for the prevention of pneumococcal diseases caused by specific serotypes. This vaccine is administered intramuscularly and is intended to stimulate the body's immune response to provide protection against pneumococcal infections. It is often recommended for individuals at higher risk of contracting these infections.

Common effects of Capvaxive may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever or fatigue following vaccination. These effects are generally mild and short-lived.

Capvaxive should be administered by healthcare professionals. Individuals with known allergies to any component of the vaccine should avoid its use. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

There are no specific interactions widely reported with Capvaxive. However, it is always advisable to inform your healthcare provider about any medications or supplements you are taking before receiving the vaccine to ensure safety.